Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE/ACE2 Ratio in Diabetic Patients Treated With Candesartan
NCT00192803Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in type 2 diabetes mellitus (T2DM), sponsored by Rambam Health Care Campus. Status: unknown.
02
Drugs
candesartan
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00192803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192803.